Evaluation of Ampicillin- Lactose Incompatibility Reactions at Solid-State Using Physicochemical Methods

Amir Ali Babazadeh miyandoab, Leila Barghi, Nesa Yousefi, F. Ghaderi
{"title":"Evaluation of Ampicillin- Lactose Incompatibility Reactions at Solid-State Using Physicochemical Methods","authors":"Amir Ali Babazadeh miyandoab, Leila Barghi, Nesa Yousefi, F. Ghaderi","doi":"10.52547/rabms.8.2.69","DOIUrl":null,"url":null,"abstract":"Background & Aims : One of the significant steps in the preformulation of pharmaceutical dosage forms is to examine active pharmaceutical ingredient (API) compatibility with the excipients applied with it. Drug-excipient incompatibility affects the stability, effectiveness, safety, and quality of the final product. Therefore, it is vital, for fruitful drug production, to sort out excipients compatible with the active pharmaceutical ingredient. The aim of this study was to evaluate the compatibility of ampicillin with lactose through differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR) physicochemical methods. Materials & Methods : To formulate powder samples, 300 mg ampicillin and lactose powder was discharged into a vial in a ratio of 1: 1, and 20% v/w water was added and then vortexed. Also, samples of pure drug and pure excipient were prepared by the same method. The direct compression method was applied to formulate the tablet samples. The samples were stored at 60° C in the oven and possible incompatibilities were examined for four consecutive weeks by observing the DSC thermograms and FTIR spectra. Results : According to the results, it is recommended to eschew the formulation of ampicillin with lactose for possible incompatibilities. Conclusion : Based on the obtained results and the changes in the main peaks of absorption of the drug-excipient mixture in the fourth week compared to the first day, there is the possibility of incompatibility in the mixture of ampicillin and lactose. Also, the observation of discoloration in the powder and tablets in the fourth week compared to the first day indicates the occurrence of a kind of incompatibility in the drug-excipient mixture.","PeriodicalId":16970,"journal":{"name":"Journal of Research in Applied and Basic Medical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Applied and Basic Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/rabms.8.2.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background & Aims : One of the significant steps in the preformulation of pharmaceutical dosage forms is to examine active pharmaceutical ingredient (API) compatibility with the excipients applied with it. Drug-excipient incompatibility affects the stability, effectiveness, safety, and quality of the final product. Therefore, it is vital, for fruitful drug production, to sort out excipients compatible with the active pharmaceutical ingredient. The aim of this study was to evaluate the compatibility of ampicillin with lactose through differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR) physicochemical methods. Materials & Methods : To formulate powder samples, 300 mg ampicillin and lactose powder was discharged into a vial in a ratio of 1: 1, and 20% v/w water was added and then vortexed. Also, samples of pure drug and pure excipient were prepared by the same method. The direct compression method was applied to formulate the tablet samples. The samples were stored at 60° C in the oven and possible incompatibilities were examined for four consecutive weeks by observing the DSC thermograms and FTIR spectra. Results : According to the results, it is recommended to eschew the formulation of ampicillin with lactose for possible incompatibilities. Conclusion : Based on the obtained results and the changes in the main peaks of absorption of the drug-excipient mixture in the fourth week compared to the first day, there is the possibility of incompatibility in the mixture of ampicillin and lactose. Also, the observation of discoloration in the powder and tablets in the fourth week compared to the first day indicates the occurrence of a kind of incompatibility in the drug-excipient mixture.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用物理化学方法评价氨苄西林-乳糖不相容反应
背景与目的:药物剂型预配制的重要步骤之一是检查原料药与辅料的相容性。药物-赋形剂不相容影响最终产品的稳定性、有效性、安全性和质量。因此,筛选出与药物活性成分相匹配的赋形剂,对药品生产的顺利进行至关重要。本研究采用差示扫描量热法(DSC)和傅里叶变换红外光谱(FTIR)等理化方法评价氨苄西林与乳糖的相容性。材料与方法:将氨苄西林和乳糖粉300 mg按1:1的比例倒入小瓶中,加入20% v/w的水,然后旋流制备粉末样品。用同样的方法制备了纯药物和纯赋形剂样品。采用直接压缩法制备片剂样品。样品在60°C的烘箱中保存,通过观察DSC热像图和FTIR光谱连续四周检查可能的不相容性。结果:根据结果,建议避免氨苄西林与乳糖配伍。结论:根据所获得的结果和第4周与第1天相比药物-辅料混合物的主要吸收峰的变化,氨苄西林与乳糖混合物可能存在配伍不相容的情况。同时,观察第四周的粉剂和片剂与第一天相比的变色情况,说明药物-赋形剂混合物中出现了一种不相容。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An observational study on effect of breathing exercise on quality of recovery among postoperative patients A Patient with Brucella with initial Manifestations similar to Crimean Congo Fever Role of fetal autopsy and its importance in intrauterine fetal death: Histopathological diagnosis Seroprevalence of cytomegalovirus infection in the patients with chronic lymphocytic leukemia Pattern of Serum Liver Enzymes in the Patients with Type 2 Diabetes Mellitus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1